Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension

A. M. Bakr, A. F. Abdalla, H. El-Marsafawy, I. Abu-Hashem, M. Ezz El-Regal, T. Amer, M. K. Abdel-Khalik, H. Mostafa, Hassan H Hassan

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Plasma endothelin-1 (ET-1) is a potent vasoconstrictor peptide involved in the pathogenesis of several disorders. Endothelin-1 concentrations are increased in adult patients with cirrhosis. However, little is known about ET-1 concentrations in children with cirrhosis. Methods: Radioimmune assay was used to measure plasma ET-1 concentrations in 19 children with cirrhosis (8 patients with ascites, and 11 without ascites), and 11 age- and sex-matched healthy children. The plasma ET-1 concentrations were correlated with the mean blood pressure, creatinine clearance, and severity of portal hypertension, as measured by portal flow volume and portal flow velocity. Results: Patients with cirrhosis and ascites had increased plasma ET-1 concentrations compared with patients who did not have ascites (6.8 pg/mL ± 0.62 pg/mL vs. 4.6 pg/mL ± 0.35 pg/mL; mean ± SEM; P < 0.01) and controls (3.6 pg/mL ± 0.27 pg/mL; mean ± SEM; P < 0.0005). Plasma ET-1 concentrations were higher in patients with cirrhosis who did not have ascites compared with controls (P < 0.005). No significant differences were observed between concentrations of the patients with cholestasis and those without cholestasis (5.4 pg/mL ± 0.52 pg/mL vs. 5.2 ± 0.32 pg/mL; mean ± SEM; P = 0.1). Plasma ET-1 concentrations correlated positively with the mean blood pressure (r = 0.58; P < 0.05) and negatively with renal function, as measured by creatinine clearance (r = -0.7; P <0.005). However, no correlation was detected between ET-1 concentrations and portal flow volume (r = -0.02; P ± 0.4) or portal flow velocity (r = -0.16; P = 0.4). Conclusions: Plasma ET-1 concentrations are increased in children with cirrhosis, with or without ascites, compared with controls. Patients with cirrhosis and ascites have increased ET-1 concentrations compared with those without ascites. The degree of increase does not relate to the severity of portal hypertension. This increase tends to maintain systemic blood pressure but is associated with a decrease in renal function.

Original languageEnglish (US)
Pages (from-to)149-153
Number of pages5
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume35
Issue number2
DOIs
StatePublished - Aug 2002

Fingerprint

portal hypertension
endothelins
Portal Hypertension
Endothelin-1
renal function
ascites
Fibrosis
Ascites
Kidney
blood pressure
cholestasis
Cholestasis
Blood Pressure
creatinine
Creatinine
vasoconstrictor agents
Vasoconstrictor Agents

Keywords

  • Ascites
  • Cirrhosis
  • Endothelin
  • Hemodynamics

ASJC Scopus subject areas

  • Gastroenterology
  • Histology
  • Medicine (miscellaneous)
  • Food Science
  • Pediatrics, Perinatology, and Child Health

Cite this

Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension. / Bakr, A. M.; Abdalla, A. F.; El-Marsafawy, H.; Abu-Hashem, I.; El-Regal, M. Ezz; Amer, T.; Abdel-Khalik, M. K.; Mostafa, H.; Hassan, Hassan H.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 35, No. 2, 08.2002, p. 149-153.

Research output: Contribution to journalArticle

Bakr, A. M. ; Abdalla, A. F. ; El-Marsafawy, H. ; Abu-Hashem, I. ; El-Regal, M. Ezz ; Amer, T. ; Abdel-Khalik, M. K. ; Mostafa, H. ; Hassan, Hassan H. / Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension. In: Journal of Pediatric Gastroenterology and Nutrition. 2002 ; Vol. 35, No. 2. pp. 149-153.
@article{63a119efac8b486494eec08d7018ae18,
title = "Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension",
abstract = "Background: Plasma endothelin-1 (ET-1) is a potent vasoconstrictor peptide involved in the pathogenesis of several disorders. Endothelin-1 concentrations are increased in adult patients with cirrhosis. However, little is known about ET-1 concentrations in children with cirrhosis. Methods: Radioimmune assay was used to measure plasma ET-1 concentrations in 19 children with cirrhosis (8 patients with ascites, and 11 without ascites), and 11 age- and sex-matched healthy children. The plasma ET-1 concentrations were correlated with the mean blood pressure, creatinine clearance, and severity of portal hypertension, as measured by portal flow volume and portal flow velocity. Results: Patients with cirrhosis and ascites had increased plasma ET-1 concentrations compared with patients who did not have ascites (6.8 pg/mL ± 0.62 pg/mL vs. 4.6 pg/mL ± 0.35 pg/mL; mean ± SEM; P < 0.01) and controls (3.6 pg/mL ± 0.27 pg/mL; mean ± SEM; P < 0.0005). Plasma ET-1 concentrations were higher in patients with cirrhosis who did not have ascites compared with controls (P < 0.005). No significant differences were observed between concentrations of the patients with cholestasis and those without cholestasis (5.4 pg/mL ± 0.52 pg/mL vs. 5.2 ± 0.32 pg/mL; mean ± SEM; P = 0.1). Plasma ET-1 concentrations correlated positively with the mean blood pressure (r = 0.58; P < 0.05) and negatively with renal function, as measured by creatinine clearance (r = -0.7; P <0.005). However, no correlation was detected between ET-1 concentrations and portal flow volume (r = -0.02; P ± 0.4) or portal flow velocity (r = -0.16; P = 0.4). Conclusions: Plasma ET-1 concentrations are increased in children with cirrhosis, with or without ascites, compared with controls. Patients with cirrhosis and ascites have increased ET-1 concentrations compared with those without ascites. The degree of increase does not relate to the severity of portal hypertension. This increase tends to maintain systemic blood pressure but is associated with a decrease in renal function.",
keywords = "Ascites, Cirrhosis, Endothelin, Hemodynamics",
author = "Bakr, {A. M.} and Abdalla, {A. F.} and H. El-Marsafawy and I. Abu-Hashem and El-Regal, {M. Ezz} and T. Amer and Abdel-Khalik, {M. K.} and H. Mostafa and Hassan, {Hassan H}",
year = "2002",
month = "8",
doi = "10.1097/00005176-200208000-00009",
language = "English (US)",
volume = "35",
pages = "149--153",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension

AU - Bakr, A. M.

AU - Abdalla, A. F.

AU - El-Marsafawy, H.

AU - Abu-Hashem, I.

AU - El-Regal, M. Ezz

AU - Amer, T.

AU - Abdel-Khalik, M. K.

AU - Mostafa, H.

AU - Hassan, Hassan H

PY - 2002/8

Y1 - 2002/8

N2 - Background: Plasma endothelin-1 (ET-1) is a potent vasoconstrictor peptide involved in the pathogenesis of several disorders. Endothelin-1 concentrations are increased in adult patients with cirrhosis. However, little is known about ET-1 concentrations in children with cirrhosis. Methods: Radioimmune assay was used to measure plasma ET-1 concentrations in 19 children with cirrhosis (8 patients with ascites, and 11 without ascites), and 11 age- and sex-matched healthy children. The plasma ET-1 concentrations were correlated with the mean blood pressure, creatinine clearance, and severity of portal hypertension, as measured by portal flow volume and portal flow velocity. Results: Patients with cirrhosis and ascites had increased plasma ET-1 concentrations compared with patients who did not have ascites (6.8 pg/mL ± 0.62 pg/mL vs. 4.6 pg/mL ± 0.35 pg/mL; mean ± SEM; P < 0.01) and controls (3.6 pg/mL ± 0.27 pg/mL; mean ± SEM; P < 0.0005). Plasma ET-1 concentrations were higher in patients with cirrhosis who did not have ascites compared with controls (P < 0.005). No significant differences were observed between concentrations of the patients with cholestasis and those without cholestasis (5.4 pg/mL ± 0.52 pg/mL vs. 5.2 ± 0.32 pg/mL; mean ± SEM; P = 0.1). Plasma ET-1 concentrations correlated positively with the mean blood pressure (r = 0.58; P < 0.05) and negatively with renal function, as measured by creatinine clearance (r = -0.7; P <0.005). However, no correlation was detected between ET-1 concentrations and portal flow volume (r = -0.02; P ± 0.4) or portal flow velocity (r = -0.16; P = 0.4). Conclusions: Plasma ET-1 concentrations are increased in children with cirrhosis, with or without ascites, compared with controls. Patients with cirrhosis and ascites have increased ET-1 concentrations compared with those without ascites. The degree of increase does not relate to the severity of portal hypertension. This increase tends to maintain systemic blood pressure but is associated with a decrease in renal function.

AB - Background: Plasma endothelin-1 (ET-1) is a potent vasoconstrictor peptide involved in the pathogenesis of several disorders. Endothelin-1 concentrations are increased in adult patients with cirrhosis. However, little is known about ET-1 concentrations in children with cirrhosis. Methods: Radioimmune assay was used to measure plasma ET-1 concentrations in 19 children with cirrhosis (8 patients with ascites, and 11 without ascites), and 11 age- and sex-matched healthy children. The plasma ET-1 concentrations were correlated with the mean blood pressure, creatinine clearance, and severity of portal hypertension, as measured by portal flow volume and portal flow velocity. Results: Patients with cirrhosis and ascites had increased plasma ET-1 concentrations compared with patients who did not have ascites (6.8 pg/mL ± 0.62 pg/mL vs. 4.6 pg/mL ± 0.35 pg/mL; mean ± SEM; P < 0.01) and controls (3.6 pg/mL ± 0.27 pg/mL; mean ± SEM; P < 0.0005). Plasma ET-1 concentrations were higher in patients with cirrhosis who did not have ascites compared with controls (P < 0.005). No significant differences were observed between concentrations of the patients with cholestasis and those without cholestasis (5.4 pg/mL ± 0.52 pg/mL vs. 5.2 ± 0.32 pg/mL; mean ± SEM; P = 0.1). Plasma ET-1 concentrations correlated positively with the mean blood pressure (r = 0.58; P < 0.05) and negatively with renal function, as measured by creatinine clearance (r = -0.7; P <0.005). However, no correlation was detected between ET-1 concentrations and portal flow volume (r = -0.02; P ± 0.4) or portal flow velocity (r = -0.16; P = 0.4). Conclusions: Plasma ET-1 concentrations are increased in children with cirrhosis, with or without ascites, compared with controls. Patients with cirrhosis and ascites have increased ET-1 concentrations compared with those without ascites. The degree of increase does not relate to the severity of portal hypertension. This increase tends to maintain systemic blood pressure but is associated with a decrease in renal function.

KW - Ascites

KW - Cirrhosis

KW - Endothelin

KW - Hemodynamics

UR - http://www.scopus.com/inward/record.url?scp=0036667769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036667769&partnerID=8YFLogxK

U2 - 10.1097/00005176-200208000-00009

DO - 10.1097/00005176-200208000-00009

M3 - Article

C2 - 12187289

AN - SCOPUS:0036667769

VL - 35

SP - 149

EP - 153

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 2

ER -